Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
迷幻輔助療法的進步爲科羅拉多州的心理健康開闢了新的視野
Recent advancements within the field of mental health with the use of psilocybin-assisted therapy, as well as Colorado's forward-thinking legislation about this therapy, have proven exciting.
事實證明，最近使用迷幻藥輔助療法在心理健康領域取得的進展，以及科羅拉多州關於這種療法的前瞻性立法，都令人興奮。
Psilocybin-assisted therapy showcased promising results in treating Generalized Anxiety Disorder (GAD). This condition often leaves individuals grappling with excessive worry and anxiety for extended periods. A Phase 2 clinical trial conducted by Incannex Healthcare (OTC:IXHL) illuminated the potential of psilocybin therapy to offer relief where traditional treatments may falter due to side effects or high costs associated with conventional methods.
psilocybin輔助療法在治療廣泛性焦慮症（GAD）方面顯示出令人鼓舞的結果。這種情況常常使個人長期遭受過度憂慮和焦慮的困擾。Incannex Healthcare（場外交易代碼：IXHL）進行的一項2期臨床試驗闡明瞭迷幻藥療法在傳統治療可能因副作用或與傳統方法相關的高成本而步履蹣跚，提供緩解的潛力。
Amidst these clinical breakthroughs, in Colorado, the city of Denver...
在這些臨床突破中，在...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。